Journal of Commercial Biotechnology
The Journal of Commercial Biotechnology is a peer-reviewed academic journal covering the business of biotechnology. Topics covered include biotechnology management, policy, finance, law, and regulations.
| Discipline | Biotechnology |
|---|---|
| Language | English |
| Publication details | |
| History | 1992 to present |
| Publisher | |
| Standard abbreviations | |
| ISO 4 | J. Commer. Biotechnol. |
| Indexing | |
| ISSN | 1462-8732 (print) 1478-565X (web) |
| Links | |
The Journal of Commercial Biotechnology was founded by Henry Stewart Publications in 1992 as the Journal of Biotechnology in Healthcare,[1] and changed its name to the Journal of Commercial Biotechnology in 1998.[2] The journal was later published by Palgrave MacMillan[3] and was purchased by thinkBiotech[4] in 2010. It is published quarterly. An external Editorial Board assists with peer review. The current editor of the Journal of Commercial Biotechnology is Yali Friedman, who has served since 2007.
References
- "Business profile for kumclibrary.org provided by Network Solutions". Archived from the original on 25 March 2012. Retrieved 21 June 2011.
- Journal of Commercial Biotechnology. WorldCat. OCLC 41491559.
- "IngentaConnect Publication: Journal of Commercial Biotechnology". www.ingentaconnect.com. Archived from the original on 1 March 2006.
- "ThinkBiotech Global biopharmaceutical innovation expert speaker - Yali Friedman, Ph.D."
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.